BiotechTube

JZP-258

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Narcolepsy

Conditions

Narcolepsy

Trial Timeline

Mar 22, 2021 → Nov 15, 2022

NCT ID
NCT04794491

About JZP-258

JZP-258 is a approved stage product being developed by Jazz Pharmaceuticals for Narcolepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT04794491. Target conditions include Narcolepsy.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (2)

NCT IDPhaseStatus
NCT04794491ApprovedCompleted
NCT03030599Phase 3Completed

Competing Products

20 competing products in Narcolepsy

See all competitors
ProductCompanyStageHype Score
E2086 + E2086 Placebo + Active Comparator + Active Comparator PlaceboEisaiPhase 1
33
MK-6552 + PlaceboMerckPhase 1
33
Sodium Oxybate (Xyrem)UCBPhase 1
30
JZP-110 + PlaceboJazz PharmaceuticalsPhase 2
49
ADX-N05 + PlaceboJazz PharmaceuticalsPhase 2
49
XyremJazz PharmaceuticalsPhase 3
74
JZP258Jazz PharmaceuticalsApproved
82
ADX-N05 + PlaceboJazz PharmaceuticalsPhase 2
49
Xyrem (sodium oxybate) oral solutionJazz PharmaceuticalsPhase 3
74
JZP441 + Matching PlaceboJazz PharmaceuticalsPhase 1
30
Xyrem + Xyrem Placebo + Modafinil at established dose + Modafinil (Placebo)Jazz PharmaceuticalsPhase 3
74
JZP-110 + Placebo oral tabletJazz PharmaceuticalsPhase 3
74
JZP-258Jazz PharmaceuticalsPhase 3
74
Transition from Xyrem to XywavJazz PharmaceuticalsPre-clinical
20
JZP-110Jazz PharmaceuticalsPhase 3
74
Sunosi (solriamfetol) + Other prescription wake-promoting medications or stimulantsAxsome TherapeuticsPre-clinical
20
AXS-12 (reboxetine) + PlaceboAxsome TherapeuticsPhase 3
74
Solriamfetol 150 mg Oral TabletAxsome TherapeuticsPhase 1
30
AXS-12 (Reboxetine) + PlaceboAxsome TherapeuticsPhase 2
49
AXS-12 (reboxetine) + PlaceboAxsome TherapeuticsPhase 3
74

Other Products from Jazz Pharmaceuticals

Sativex + PlaceboApproved
82
Sodium OxybateApproved
82
JZP258Approved
82
Solriamfetol + PlaceboApproved
82
Placebo + Sodium OxybateApproved
82